close

Login

Library
Shopping Cart
Remember Me
Forgot password/Login issues?
loading animation for AJAX calls
 
 
Direct (781) 489-7301,  Toll Free (866) 285-7215

Search

Search
BCC Advance Search

Global Pharmaceutical Markets

  • Published: May 2008
  • |
  • Report Code: PHM037B

REPORT HIGHLIGHTS

  • The global market for pharmaceuticals increased from $693.7 billion in 2007 to an estimated $737.6 billion by the end of 2008. It should reach over $1 trillion by 2013, a compound annual growth rate (CAGR) of 6.9%.
  • The generic prescription drugs segment will experience the highest growth rate over the study period. Worth an estimated $88.7 billion in 2008, it will reach $151.4 billion by the end of 2013, a CAGR of 11.3%.
  • The world’s best selling pharmaceutical product, Lipitor, had revenues of $12.7 billion in 2007.

Download Free Chapter

REPORT SCOPE

INTRODUCTION

STUDY GOALS AND OBJECTIVES
 
This study examines world pharmaceutical markets and provides pertinent information about sales and production of pharmaceutical products, as well as information about national healthcare systems and drug pricing policies. The report covers 24 countries in detail and provides links to relevant information. There are also profiles of larger pharmaceutical and biotechnology companies, complete with revenue histories.
 
Trends in government policies concerning drug pricing and reimbursement are examined. The report also makes predictions about countries whose pharmaceutical market growth is likely to grow radically in the next 5 years.
 
REASONS FOR DOING THE STUDY
 
Although the pharmaceutical industry remains one of the most profitable and stable industries in the world, several variables are forcing fundamental changes in its structure. They are: 
  • Increasing government-imposed price reductions in prices
  • An increasing role of generic substitutes (especially in Europe)
  • The emergence of bio-pharmaceuticals and the bio-omics revolution
  • Increasing buyer power of third-party payers, government buyers, and health maintenance organizations
  • Increased health awareness among patients and government buyers
  • Changing suppliers—enhanced outsourcing, in-licensing, contract research, and manufacturing activities.
Additionally, changing world demographics are influencing the pharmaceutical industry. They include population aging, declining research and development (R&D) productivity, and the General Agreements on Tariffs and Trade (GATT) and Trade Related Intellectual Property Rights (TRIPS).
 
AUDIENCE FOR THE REPORT
 
This report is directed at decision-makers in each industry segment, as well as at individuals and organizations considering investing in drug discovery or drug discovery technology. These people include, but are not limited to the following: 
  • Business development professionals
  • Venture capitalists
  • Merger and acquisition executives
  • Market and product management professionals
  • Chief scientists and technical officers
  • Equipment manufacturers
  • Reagent suppliers
SCOPE AND FORMAT
 
The scope of this study encompasses the major sectors of the world pharmaceutical industry and major geographical markets. BCC Research has analyzed the forces affecting the world pharmaceutical markets, determined their impact on the market demand and growth, and also presented the growth forecast over the next 5 years. Key forces include the increasing role of substitutes (generic pharmaceuticals), threat of new entrants (biopharmaceuticals), increasing role of buyers (governments, insurance, etc.), and changing suppliers.
 
BCC Research has provided the comprehensive analyses of the industry on the worldwide basis and also provided the detailed profiles for 25 leading pharmaceutical markets across the globe. For each of the geographical markets, we have presented the sector information, pharmaceutical distribution and pricing, and reimbursement and regulations. In a nutshell, the report provides the reader with a one-stop analysis of the worldwide pharmaceutical industry.
  
METHODOLOGY AND INFORMATION SOURCES
 
Market data and other information used in this report was gathered from interviews with individuals in the industry, as well as a thorough review of technology and markets gathered from secondary sources. These sources include company annual, 10K and 10Q reports, company literature, trade literature, trade associations, and online sources. Note that the author of this report is herself involved in the development of a compound for amyotrophic lateral sclerosis.
 
Projections were based on current and historical levels of funding and revenues, potential end users, likely unit prices and rates of consumption. Final projections are based on the analysis of information from primary and secondary sources. All currency conversions were made based on the average value of the dollar during the last month of the year in question. In some cases, data is provided in the original currency for readers wishing to make their own comparisons. An online currency converter was used for this purpose. All forecasts are presented in year 2008 constant dollars.

Download Free Chapter

REPORT TOC

download table of contents
Pricing on the website is provided for single users and 2-5 users licenses only. All reports will be provided in a PDF format for download. To purchase multi-user licenses, please contact us at (+1)781-489-7301 or send an email to information@bccresearch.com
  Title/Chapter Name Pages Price
Global Pharmaceutical Markets 335 $3658
Chapter- 1: INTRODUCTION - Complimentary 4 $0
  Show Details
Chapter- 2: SUMMARY 4 $250
  Show Details
Chapter- 3: OVERVIEW 4 $66
  Show Details
Chapter- 4: THE PHARMACEUTICAL INDUSTRY 4 $66
  Show Details
Chapter- 5: UNITED STATES 50 $819
  Show Details
Chapter- 6: CANADA 18 $295
  Show Details
Chapter- 7: MEXICO 9 $147
  Show Details
Chapter- 8: BRAZIL 6 $98
  Show Details
Chapter- 9: EUROPE 9 $147
  Show Details
Chapter- 10: FRANCE 21 $344
  Show Details
Chapter- 11: GERMANY 19 $311
  Show Details
Chapter- 12: UNITED KINGDOM (U.K.) 19 $311
  Show Details
Chapter- 13: ITALY 15 $246
  Show Details
Chapter- 14: SPAIN 14 $229
  Show Details
Chapter- 15: SMALLER PHARMACEUTICAL MARKETS IN EUROPE 87 $1425
  Show Details
Chapter- 16: ASIA 52 $852
  Show Details
 
  List of Tables
  List of Figures
 
Select License type:
buy now
download free chapter
Want to find out more
about this report?
request more info
Get Notified
on all the latest research reports
Subscribe

Choose your License

loading animation for AJAX calls